ITPC EECA retweeted
Eastern Europe & Central Asia's multistakeholder consultation with 60+ representatives concluded: Urgent Innovative Solutions needed to #endAIDS
🔹 Radically refocus investments
🔹 Scale up services for key pops&migrants
🔹 Dismantle legal barriers
🔹 Support community leadership
We are excited to share with you the video from the AIDS 2024 featuring a very important guest - Eamonn Murphy, Regional Director of the @UNAIDS_EECA in Eastern Europe and Central Asia and the Pacific region.
👉🏻 Video in English with Russian subtitles youtu.be/Yis5NSmPnP0?si=-SpH…
ITPC EECA retweeted
.@t_abdullaev @OlyaKlymenko in podcast about #TB in #Uzbekistan (in russian)
@ITPCru
youtube.com/live/v8X0C21FF78
ITPC EECA retweeted
On May 14, 3pm-4pm CET, TBEC in collaboration with ITPC EECA, as part of the series "The ABCs of a TB Activist" will host the webinar "Campaign 1/4/6x24: From Promises to Action"👉us02web.zoom.us/meeting/regi…
Speaker Madlen Nash will present aTAG's report on campaign implementation
ITPC EECA retweeted
Live from the @DanaherCorp/Cepheid HQ in Washington, DC: this #WorldTBDay, advocates demand the company reduce the price of diagnostic tests for drug-resistant TB + other diseases to $5.
Danaher, it’s Time for $5!
ITPC EECA retweeted
Just released: TB Treatment Pipeline Report 2023, detailing key updates in TB treatment R&D - including recently wrapped and in-progress treatment-shortening trials, and 22 new or repurposed drugs undergoing clinical trials. Read it here: treatmentactiongroup.org/res… #CROI2024
Патрик Агбасси - роль сообществ в борьбе с ТБ /Patrick Agbassi - the role of communities in the fight against TB
The video interview in English with Russian subtitles is available at the following link: youtu.be/wbFYafYpAIQ?si=QSJ9…
Welcome 🙌🏻
@StopTB @msf_tb @WHO_Europe_TB
#endtb
Друзья и коллеги, 21 декабря в 12:00 по центральноевропейскому времени (CET) мы проведем праздничный подкаст «Четвертая лошадь» выпуск «Рождественская ZOOM-рулетка».
📹youtube.com/@ITPCEECATV?si=b…
ITPC EECA retweeted
Denis Godlevsky, @ITPCru, TB People member, interviewed Dr. @LucicaDitiu — Executive Director of @StopTB, honorary member of TB People.
The topic of the conversation is can we #endTB?
youtube.com/watch?v=yTSC6UAo….
We are pleased to present to you the first video from the series of interviews at the UNION conference. In this episode - Dr Lucica Ditiu, the Executive Director of the @StopTB . The video is in English with Russian subtitles: youtu.be/yTSC6UAoIa4?si=hpz1…
🌏WHO has announced the launch of a new web-based tool, ScreenTB, to help countries prioritize TB screening and prevention.
👉🏻To use the platform, you need to follow this link: screentb.org/input
ВОЗ объявила о запуске нового веб-инструмента – ScreenTB, который предназначен для помощи странам в определении приоритетных задач по скринингу и профилактике ТБ. Чтобы воспользоваться платформой, необходимо перейти по ссылке: screentb.org/input
🤝🏻👍🏻
Our first TB Pipeline report of 2023 is here: "TB Vaccines" by Mike Frick analyzes landscape of 17 TB vax candidates in various stages of R&D, including several in Phase III trials. More resources - especially from governments + industry - still needed! treatmentactiongroup.org/res…
🤝🏻 Egypt has become the first country to achieve the "gold tier” status on the path to elimination of hepatitis C as per WHO criteria.
Full text in Russian: itpc-eeca.org/2023/10/10/voz…
📢 Уже совсем скоро будет проходить 19-я Европейская конференция по СПИДу
ITPC EECA будет следить за конференцией и делиться самыми интересными докладами и исследованиями.
📩Следите за новостями.
☄️This is the first compulsory license for dolutegravir, and this is somewhat strange because dolutegravir is a key drug for the treatment of HIV infection.
🤝🏻It is encouraging to see that there are countries taking action to improve access to treatment for their citizens.
Desde Fundación GEP celebramos la Declaración de interés público para Dolutegravir de #Colombia, un paso previo para la licencia obligatoria.
📢 On September 29, Johnson & Johnson published a press release on its website in which it confirmed that it will not interfere with the production and supply of generic bedaquiline (TN SIRTURO) in low- and middle-income countries.
👉🏻 full text in Russian: urlog.ru/auLEDe
Global Fund, Stop TB Partnership and USAID have shared this morning that Cepheid and Danaher are announcing an 20% drop in price for GeneXpert TB test in high-TB-burden countries.
С годовщиной ITPC!
Видеопоздравление с русскими субтитрами: youtu.be/BOazI3wJcXQ?si=xZR2…
✊We are proud to present this special edition 20th Anniversary Annual Review which encapsulates the spirit of our shared mission to achieve health & social justice through robust community engagement.
🔗itpcglobal.org/blog/resource…


















